And theyre not completely wrong to be concerned Clinical studies do show that people on GLP-1 medications lose some lean muscle mass alongside body fat
Studies that used 1 mg/day in oral and intravenous trials did not show meaningfully better outcomes than lower doses, and higher doses were associated with more reports of headache, diarrhea, and gastrointestinal effects
Especially beyond the GLP-1 agonist journey
Metformin Metformin is one of the few medications considered generally safe during breastfeeding that also supports weight management
However, nucleic acid therapy containing small interfering RNA (He et al., 2014), microRNA, aptamers (Zhou et al., 2016), and immune adjuvant nucleic acids (Zhang et al., 2018), still faces several obstacles: low solubility, instability, weak permeability, uncontrolled drug release kinetics and lack of target specificity